NeoGenomics Beats Investor Suit Over Growth Driver Claims

By Emilie Ruscoe · March 17, 2026, 9:55 PM EDT

Cancer diagnostics company NeoGenomics Inc. no longer faces a proposed investor class action alleging it mischaracterized its growth drivers, including by failing to disclose that a rainmaking unit potentially ran afoul...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login